Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice

Marcello Arca(Sapienza University of Rome), Alberico L. Catapano(University of Milan)

Atherosclerosis

February 17, 2018

10.1016/j.atherosclerosis.2018.02.024

Cited by 39

Related Papers

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

|European Heart Journal|2022|1.2k

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

|European Heart Journal|2021|869

The 15-Lipoxygenase-Modified High Density Lipoproteins 3 Fail to Inhibit the TNF-α-Induced Inflammatory Response in Human Endothelial Cells

|The Journal of Immunology|2008|29